BridgeMD
Tests treatment safety and results for Pneumococcal Disease
Official title Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
ClinicalTrials.gov ID: NCT07660198
What this study is testing
What is PG4?
PG4 is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for pneumococcal disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in children when compared to the pneumococcal vaccine that is currently in use, 20vPnC (Prevnar 20®). This study will test if the new pneumococcal vaccine is as safe as the one that is currently in use.
- Phase 3: a large, late-stage study
- Time commitment: about 6 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 17. Healthy volunteers may be eligible.
You may be able to join if
- Cohort 1 (Participants ≥15 Months to \<2 Years of Age) Healthy toddlers and children ≥15 months to \<2 years of age with documentation of prior...
- Cohort 2 (Participants ≥2 Years to \<5 Years of Age) Healthy toddlers and children ≥2 years to \<5 years of age with documentation of prior receipt...
- Cohort 3 (Participants ≥5 Years to \<18 Years of Age) Healthy children ≥5 years to \<18 years of age with documentation of prior receipt of PCV (if...
You likely can't join if
- All Cohorts (Participants ≥15 Months to \<18 Years of Age)
- Children with significant medical, psychiatric, or neurological conditions (eg, immunodeficiency or history of seizure); or a history of confirmed...
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Fair Oaks, California, United States
- Ontario, California, United States
- Miami Lakes, Florida, United States
- Ammon, Idaho, United States
- Blackfoot, Idaho, United States
- Boise, Idaho, United States
- Bardstown, Kentucky, United States
- Covington, Louisiana, United States
- Lafayette, Louisiana, United States
- Shreveport, Louisiana, United States
- Fall River, Massachusetts, United States
- Bingham Farms, Michigan, United States
- Minneapolis, Minnesota, United States
- Lincoln, Nebraska, United States
- East Syracuse, New York, United States
- Horseheads, New York, United States
- Cincinnati, Ohio, United States
- Dayton, Ohio, United States
- South Euclid, Ohio, United States
+ 13 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 15 months to 17 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Fair Oaks, California, United States; Ontario, California, United States; Miami Lakes, Florida, United States; Ammon, Idaho, United States; Blackfoot, Idaho, United States and 27 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.